Eden Bioscience Corporation (NASDAQ: EDEN) received a Nasdaq Staff Deficiency Letter from the Nasdaq Stock Market notifying it that the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE